Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 101 | 103 | +2 |
| Shares | 29.1M | 29.4M | +293.2K (+1.0%) |
| Value | $332.0M | $346.4M | +$14.4M (+4.3%) |
New holders (22)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 303,300 | $3.57M | 0.00% |
| Endurant Capital Management LP | 244,125 | $2.87M | 0.78% |
| Integral Health Asset Management, LLC | 140,000 | $1.65M | 0.46% |
| Parkman Healthcare Partners LLC | 113,644 | $1.34M | 0.30% |
| Walleye Capital LLC | 83,364 | $981.0K | 0.03% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907.0K | 0.32% |
| Marshall Wace, LLP | 69,723 | $821.0K | 0.00% |
| Pinz Capital Management, LP | 40,000 | $471.0K | 0.18% |
| Bailard, Inc. | 25,900 | $305.0K | 0.01% |
| Engineers Gate Manager LP | 24,336 | $286.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 22,126 | $260.0K | 0.00% |
| Gsa Capital Partners LLP | 16,157 | $190.0K | 0.02% |
| D. E. Shaw & Co., Inc. | 12,317 | $145.0K | 0.00% |
| Nisa Investment Advisors, LLC | 7,622 | $86.0K | 0.00% |
| Quantbot Technologies LP | 4,800 | $56.0K | 0.00% |
| Lazard Asset Management LLC | 3,759 | $44.0K | 0.00% |
| Adirondack Trust Co | 430 | $5.00K | 0.00% |
| Cornerstone Advisory, LLC | 200 | $2.00K | 0.00% |
| State of Wyoming | 151 | $2.00K | 0.00% |
| CWM, LLC | 28 | $0 | 0.00% |
| Parallel Advisors, LLC | 24 | $0 | 0.00% |
| Amplius Wealth Advisors, LLC | 35 | $0 | 0.00% |
Sold out (20)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boxer Capital, LLC | 290,577 | $3.31M |
| Woodline Partners LP | 234,357 | $2.67M |
| Rubric Capital Management LP | 153,618 | $1.75M |
| M&G Investment Management Ltd | 142,527 | $1.57M |
| Alps Advisors Inc | 83,983 | $957.0K |
| Ikarian Capital, LLC | 59,422 | $677.0K |
| Raymond James & Associates | 54,794 | $624.0K |
| Qube Research & Technologies Ltd | 32,141 | $366.0K |
| HRT Financial LP | 18,869 | $214.0K |
| SG Americas Securities, LLC | 18,551 | $211.0K |
| Jane Street Group, LLC | 17,921 | $204.0K |
| Man Group plc | 15,400 | $175.0K |
| HSBC Holdings PLC | 10,040 | $115.0K |
| DekaBank Deutsche Girozentrale | 10,000 | $114.0K |
| Federated Hermes, Inc. | 5,292 | $60.0K |
| Cutler Group LP | 1,500 | $17.0K |
| Penserra Capital Management LLC | 745 | $8.00K |
| Advisor Group Holdings, Inc. | 269 | $3.00K |
| Signaturefd, LLC | 66 | $1.00K |
| O'Shaughnessy Asset Management, LLC | 19 | $0 |